Lv62
2480 积分 2023-08-25 加入
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
18小时前
已完结
Bruton’s tyrosine kinase inhibitor zanubrutinib-based regimens in relapsed/refractory primary diffuse large B-cell lymphoma of the central nervous system
5天前
已完结
Pharmacokinetics of Single and Multiple Oral Administration of a Self‐emulsifying Formulation of Highly Purified Eicosapentaenoic Acid Ethyl Ester (MND‐2119) Compared With the Nonself‐emulsifying Formulation in Healthy Male Subjects
16天前
已完结
Discovery of Reversible Covalent Bruton’s Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib)
21天前
已完结
Streamlining Food Effect Assessment — Are Repeated Food Effect Studies Needed? An IQ Analysis
22天前
已完结
ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global Convergence
1个月前
已完结
多发性硬化诊断与治疗中国指南（2023版）
1个月前
已完结
Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine
3个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
3个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
